| 1 |
16879301 | Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. | 2006 Aug |
1 |
| 2 |
12007981 | Peptide substrates for ERK1/2: structure-function studies of serine 31 in tyrosine hydroxylase. | 2002 Apr 30 |
2 |
| 3 |
10821702 | Catalytic reaction pathway for the mitogen-activated protein kinase ERK2. | 2000 May 23 |
2 |
| 4 |
11064438 | Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients. | 2000 Oct |
1 |
| 5 |
10191299 | Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: unique apoB-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages. | 1999 Apr |
2 |
| 6 |
9395124 | Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis. | 1997 Nov 6 |
1 |
| 7 |
8862136 | A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein. | 1996 Oct |
1 |
| 8 |
8583237 | Administration of myelin basic protein synthetic peptides to multiple sclerosis patients. | 1995 Nov |
3 |
| 9 |
7507496 | Human myelin basic protein (MBP) epitopes recognized by mouse MBP-selected T cell lines from multiple sclerosis patients. | 1994 Jan |
1 |
| 10 |
8058058 | 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells. | 1994 Jul |
1 |
| 11 |
7681451 | Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis. | 1993 Mar |
2 |
| 12 |
1373999 | Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens. | 1992 Feb |
1 |
| 13 |
1377712 | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid. | 1992 Jul |
3 |
| 14 |
1381412 | Optic neuritis anti-myelin basic protein synthetic peptide specificity. | 1992 May |
2 |
| 15 |
1704014 | Assessment of antigenic determinants for the human T cell response against myelin basic protein using overlapping synthetic peptides. | 1991 Feb |
1 |
| 16 |
1907971 | Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. | 1991 Aug 15 |
2 |
| 17 |
1694729 | Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients. | 1990 Aug |
1 |
| 18 |
1694881 | Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. | 1990 Jul 15 |
1 |
| 19 |
2459156 | New monoclonal antibodies reactive with defined sequential epitopes in human myelin basic protein. | 1988 Oct |
1 |
| 20 |
2411747 | Isolation of tryptic peptides of myelin basic protein by reversed-phase high-performance liquid chromatography. | 1985 Jun 19 |
2 |
| 21 |
6083470 | Format determinants of synthetic myelin basic protein peptide S82 mimicked by a mixture of synthetic peptides S8 and S79. | 1984 Oct |
1 |
| 22 |
6157030 | Specificity of brain cathepsin D: cleavage of model peptides containing the susceptible Phe-Phe regions of myelin basic protein. | 1980 |
1 |